Insider Stock Trading History of Robin Howard W


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Robin Howard W since year 2005. The trader's CIK number is 1206869. At the time of this reporting, Robin Howard W is the President & CEO of Nektar Therapeutics . (stock ticker symbol NKTR). See this page for all insider trading activities at Nektar Therapeutics .


Stock purchases, sales, and option exercises reported by insider Robin Howard W since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-10-09 NKTR Nektar Therapeutics Sale 83,333 24.20 2,016,658
2017-10-09 NKTR Nektar Therapeutics Option Ex 83,333 11.34 944,996
2017-09-06 NKTR Nektar Therapeutics Option Ex 83,333 11.34 944,996
2017-09-06 NKTR Nektar Therapeutics Sale 83,333 21.54 1,794,992
2017-08-16 NKTR Nektar Therapeutics Option Ex 83,334 11.34 945,007
2017-08-16 NKTR Nektar Therapeutics Sale 91,714 19.29 1,768,704
2017-05-16 NKTR Nektar Therapeutics Sale 8,388 19.55 163,985
2017-02-16 NKTR Nektar Therapeutics Sale 8,636 13.14 113,477
2017-02-08 NKTR Nektar Therapeutics Sale 87,500 13.04 1,141,000
2017-02-08 NKTR Nektar Therapeutics Option Ex 87,500 4.65 406,875
2017-01-17 NKTR Nektar Therapeutics Option Ex 87,500 4.65 406,875
2017-01-17 NKTR Nektar Therapeutics Sale 87,500 12.35 1,080,625
2016-12-07 NKTR Nektar Therapeutics Sale 87,500 12.24 1,071,000
2016-12-07 NKTR Nektar Therapeutics Option Ex 87,500 4.65 406,875
2016-11-16 NKTR Nektar Therapeutics Sale 5,958 13.96 83,173
2016-11-17 NKTR Nektar Therapeutics Sale 87,500 13.87 1,213,625
2016-11-17 NKTR Nektar Therapeutics Option Ex 87,500 4.65 406,875
2016-10-04 NKTR Nektar Therapeutics Sale 87,500 17.06 1,492,750
2016-10-04 NKTR Nektar Therapeutics Option Ex 87,500 4.65 406,875
2016-09-01 NKTR Nektar Therapeutics Option Ex 87,500 4.65 406,875
2016-09-01 NKTR Nektar Therapeutics Sale 87,500 17.83 1,560,124
2016-08-16 NKTR Nektar Therapeutics Sale 11,817 17.56 207,506
2016-05-16 NKTR Nektar Therapeutics Option Ex 5,625 .00 0
2016-05-17 NKTR Nektar Therapeutics Sale 2,170 13.58 29,468
2016-02-16 NKTR Nektar Therapeutics Option Ex 5,625 .00 0
2016-02-17 NKTR Nektar Therapeutics Sale 2,147 11.92 25,592
2016-01-19 NKTR Nektar Therapeutics Option Ex 66,667 6.46 430,668
2016-01-19 NKTR Nektar Therapeutics Sale 66,667 14.12 941,338
2015-12-03 NKTR Nektar Therapeutics Option Ex 125,001 6.72 840,006
2015-12-03 NKTR Nektar Therapeutics Sale 125,001 15.87 1,983,765
2015-11-11 NKTR Nektar Therapeutics Sale 125,000 13.52 1,690,000
2015-11-11 NKTR Nektar Therapeutics Option Ex 125,000 6.72 840,000
2015-10-06 NKTR Nektar Therapeutics Option Ex 125,000 6.72 840,000
2015-10-06 NKTR Nektar Therapeutics Sale 125,000 10.99 1,373,750
2015-09-23 NKTR Nektar Therapeutics Option Ex 124,999 6.72 839,993
2015-09-23 NKTR Nektar Therapeutics Sale 124,999 13.04 1,629,986
2015-08-13 NKTR Nektar Therapeutics Sale 58,333 10.89 635,246
2015-08-13 NKTR Nektar Therapeutics Option Ex 58,333 6.98 407,164
2015-07-14 NKTR Nektar Therapeutics Option Ex 58,334 6.98 407,171
2015-07-14 NKTR Nektar Therapeutics Sale 58,334 11.78 687,174
2014-12-01 NKTR Nektar Therapeutics Sale 209,056 17.00 3,553,952
2014-11-28 NKTR Nektar Therapeutics Sale 140,944 17.02 2,398,866
2014-12-01 NKTR Nektar Therapeutics Option Ex 209,056 6.98 1,459,210
2014-11-28 NKTR Nektar Therapeutics Option Ex 140,944 6.98 983,789
2014-11-24 NKTR Nektar Therapeutics Option Ex 132,800 14.52 1,928,256
2014-11-25 NKTR Nektar Therapeutics Option Ex 467,200 14.52 6,783,744
2014-11-24 NKTR Nektar Therapeutics Sale 132,800 15.02 1,994,656
2014-11-25 NKTR Nektar Therapeutics Sale 467,200 15.31 7,152,832
2007-03-05 NKTR Nektar Therapeutics Buy 10,000 11.27 112,700

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Robin Howard W (President & CEO of Nektar Therapeutics at the time of this reporting) see the Securities and Exchange Commission (SEC) website.